Microorganism

Kraig Biocraft Laboratories Shares Industry Update on Recombinant Spider Silk from Waste Plastics

Retrieved on: 
Thursday, March 28, 2024
RPI, Dragon silk, ANN, A-DNA, Microorganism, Recycling, Pseudomonas, Microplastics, Polyethylene, Silk, Research, News, Bacteria, Food, Molecular biology, KBLB, Plastic, Rensselaer Polytechnic Institute, OTCQB

ANN ARBOR, Mich., March 28, 2024 (GLOBE NEWSWIRE) -- Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) ("Kraig Labs" or "the Company"), comments on an exciting advancement in spider silk engineering from the Rensselaer Polytechnic Institute ("RPI").

Key Points: 
  • ANN ARBOR, Mich., March 28, 2024 (GLOBE NEWSWIRE) -- Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) ("Kraig Labs" or "the Company"), comments on an exciting advancement in spider silk engineering from the Rensselaer Polytechnic Institute ("RPI").
  • Researchers at RPI published a paper in Microbial Cell Factories outlining a new and novel method of creating spider silk protein from waste plastics.
  • Kraig Labs' recombinant spider silk production model utilizes traditional silk production systems involving planting mulberry trees to harvest and feed the leaves to silkworms.
  • The Company's specialized silkworms have been scientifically enhanced through molecular biology to create recombinant spider silk cocoons that are reeled to produce spider silk yarns and fabrics.

Whole Genome Sequencing Market Global Industry Forecast Report 2018-2028, Featuring Profiles of Illumina, Agilent Technologies, 10 x Genomics, BGI, Oxford Nanopore, Nebula Genomics & Veritas Genetics

Retrieved on: 
Wednesday, January 31, 2024
Cloud, Volcanic explosivity index, Whole genome sequencing, Growth, Microbiology, Workflow, WES, Genomics, Research, AI, DNA, Bacteria, Government, Gene, Mutation, Diagnosis, Microorganism, Exon, Competition, Exome sequencing, Sequence, Next Generation, NGS, Cloud computing, Cancer, Genome, Infection, Antibiotics

DUBLIN, Jan. 31, 2024 /PRNewswire/ -- The "Whole Genome Sequencing Market - Global Industry Size, Share, Trends, Competition, Opportunity, and Forecast, 2018-2028" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • DUBLIN, Jan. 31, 2024 /PRNewswire/ -- The "Whole Genome Sequencing Market - Global Industry Size, Share, Trends, Competition, Opportunity, and Forecast, 2018-2028" report has been added to ResearchAndMarkets.com's offering.
  • The Whole Genome Sequencing Market is expected to grow with an impressive CAGR in the forecast period 2024-2028.
  • Increasing technological advancement in NGS instruments and update in technology utilized in Sequencing techniques are adding to further drive the sequencing market growth in the forecast period.
  • In this report, Whole Genome Sequencing Market has been segmented into the following categories:

Rheonix Inc. Publishes Cyclospora cayetanensis Data in Collaboration With FDA Center for Food Safety and Applied Nutrition

Retrieved on: 
Wednesday, January 10, 2024
Research, Medical Devices, Infectious Diseases, FDA, Biotechnology, Health, Agriculture, Science, Natural Resources, Inc., Microorganism, Food, DNA, RCA, Applied science, CFSAN, Biological life cycle, Workflow, Risk, Cyclospora cayetanensis, CDC, Cyclosporiasis, PCR, Soil

announces joint publication with the Food and Drug Administration (FDA) of collaborative data confirming the detection of Cyclospora cayetanensis (C. cayetanensis) in produce samples.

Key Points: 
  • announces joint publication with the Food and Drug Administration (FDA) of collaborative data confirming the detection of Cyclospora cayetanensis (C. cayetanensis) in produce samples.
  • The data verify the performance of the fully automated Rheonix C. cayetanensis™ assay developed under a Research Collaboration Agreement (RCA) between Rheonix and the Office of Applied Research and Safety Assessment (OARSA) within the Center for Food Safety and Applied Nutrition (CFSAN) of the FDA.
  • The Rheonix C. cayetanensis assay is based on genetic targets developed and published by the FDA and is processed using Rheonix reagents and consumables on the Rheonix Encompass Optimum™ workstation.
  • The assay is now available for use by food and environmental testing laboratories (for more information, please visit the Rheonix website ).

Biostimulants Market worth $6.8 billion by 2028 - Exclusive Report by MarketsandMarkets™

Retrieved on: 
Thursday, December 7, 2023
Soil seed bank, Cereal, Agriculture, Research, Climate change, Plant, Seed, UPL, BASF SE, Germination, Biotechnology, Vegetable, Fungus, Haifa Group, Liquid, Fruit, USD, Farmer, Health, BASF, Bacteria, Function, FMC Corporation, Microbial inoculant, Disease resistance, Bandini s.p. 1000, Growth, Pesticide, Nature, Microorganism, SE, Soil, Transport, Fertilizer, Silviculture, Biostimulation, Region

CHICAGO, Dec. 7, 2023 /PRNewswire/ -- The Biostimulants Market is estimated at USD 3.9 billion in 2023 and is projected to reach USD 6.8 billion by 2028, at a CAGR of 11.8% from 2023 to 2028 according to a report published by MarketsandMarkets™.

Key Points: 
  • CHICAGO, Dec. 7, 2023 /PRNewswire/ -- The Biostimulants Market is estimated at USD 3.9 billion in 2023 and is projected to reach USD 6.8 billion by 2028, at a CAGR of 11.8% from 2023 to 2028 according to a report published by MarketsandMarkets™.
  • By active ingredient type, Microbial amendments is estimated to grow at the highest rate in the biostimulants market.
  • The global biostimulants market is witnessing a significant surge in interest and investment, with microbial amendments emerging as a key driver of this growth.
  • By mode of application, the seed treatment segment is estimated to grow at the highest rate in the biostimulants market.

Biostimulants Market worth $6.8 billion by 2028 - Exclusive Report by MarketsandMarkets™

Retrieved on: 
Thursday, December 7, 2023
Soil seed bank, Cereal, Agriculture, Research, Climate change, Plant, Seed, UPL, BASF SE, Germination, Biotechnology, Vegetable, Fungus, Haifa Group, Liquid, Fruit, USD, Farmer, Health, BASF, Bacteria, Function, FMC Corporation, Microbial inoculant, Disease resistance, Bandini s.p. 1000, Growth, Pesticide, Nature, Microorganism, SE, Soil, Transport, Fertilizer, Silviculture, Biostimulation, Region

CHICAGO, Dec. 7, 2023 /PRNewswire/ -- The Biostimulants Market is estimated at USD 3.9 billion in 2023 and is projected to reach USD 6.8 billion by 2028, at a CAGR of 11.8% from 2023 to 2028 according to a report published by MarketsandMarkets™.

Key Points: 
  • CHICAGO, Dec. 7, 2023 /PRNewswire/ -- The Biostimulants Market is estimated at USD 3.9 billion in 2023 and is projected to reach USD 6.8 billion by 2028, at a CAGR of 11.8% from 2023 to 2028 according to a report published by MarketsandMarkets™.
  • By active ingredient type, Microbial amendments is estimated to grow at the highest rate in the biostimulants market.
  • The global biostimulants market is witnessing a significant surge in interest and investment, with microbial amendments emerging as a key driver of this growth.
  • By mode of application, the seed treatment segment is estimated to grow at the highest rate in the biostimulants market.

Biorational Pesticides Market worth $15.1 billion by 2028 - Exclusive Report by MarketsandMarkets™

Retrieved on: 
Monday, December 4, 2023
Cereal, EPA, Pesticide, Research, Safety, Plant, UPL, BASF SE, Investment, Bayer, Fungus, Chlorpyrifos, Liquid, Deficit spending, USD, Soil, Farmer, BASF, Biopesticide, FMC Corporation, Synthetic microbial consortia, Environment, Syngenta, SE, Microorganism, Organic farming, Pyrethrin, Bacillus, Public, Agriculture, Streptomyces, Trichoderma, Pseudomonas

CHICAGO, Dec. 4, 2023 /PRNewswire/ -- The Biorational Pesticides Market will grow from USD 7.5 billion in 2023 to USD 15.1 billion by 2028, growing at a CAGR of 15.2% from 2023 to 2028 according to a report published by MarketsandMarkets™.

Key Points: 
  • CHICAGO, Dec. 4, 2023 /PRNewswire/ -- The Biorational Pesticides Market will grow from USD 7.5 billion in 2023 to USD 15.1 billion by 2028, growing at a CAGR of 15.2% from 2023 to 2028 according to a report published by MarketsandMarkets™.
  • This significant expansion in organic farming practices has notably influenced the surge in the biorational pesticides market.
  • Significant investments from both public and private sectors have been drawn to the expanding market potential of biorational pesticides.
  • Investment in research and infrastructure has further stimulated market growth, enhancing global accessibility of biorational pesticides for farmers.

Biorational Pesticides Market worth $15.1 billion by 2028 - Exclusive Report by MarketsandMarkets™

Retrieved on: 
Monday, December 4, 2023
Cereal, EPA, Pesticide, Research, Safety, Plant, UPL, BASF SE, Investment, Bayer, Fungus, Chlorpyrifos, Liquid, Deficit spending, USD, Soil, Farmer, BASF, Biopesticide, FMC Corporation, Synthetic microbial consortia, Environment, Syngenta, SE, Microorganism, Organic farming, Pyrethrin, Bacillus, Public, Agriculture, Streptomyces, Trichoderma, Pseudomonas

CHICAGO, Dec. 4, 2023 /PRNewswire/ -- The Biorational Pesticides Market will grow from USD 7.5 billion in 2023 to USD 15.1 billion by 2028, growing at a CAGR of 15.2% from 2023 to 2028 according to a report published by MarketsandMarkets™.

Key Points: 
  • CHICAGO, Dec. 4, 2023 /PRNewswire/ -- The Biorational Pesticides Market will grow from USD 7.5 billion in 2023 to USD 15.1 billion by 2028, growing at a CAGR of 15.2% from 2023 to 2028 according to a report published by MarketsandMarkets™.
  • This significant expansion in organic farming practices has notably influenced the surge in the biorational pesticides market.
  • Significant investments from both public and private sectors have been drawn to the expanding market potential of biorational pesticides.
  • Investment in research and infrastructure has further stimulated market growth, enhancing global accessibility of biorational pesticides for farmers.

New Report Outlines Microbial Solutions to Mediate Methane Emissions

Retrieved on: 
Wednesday, November 15, 2023
American Society for Microbiology, Carbon, Climate change, Sheep, Greenhouse, American Academy, American Geophysical Union, Multimedia, Climate, Methane emissions, Animal, ASM, Methane, Society, Knowledge, Role, Publication, Nursing, Microorganism, Microbiology

The report highlights recommendations to further the scientific community's understanding of microbial processes of methane production and consumption to mitigate methane emissions and address climate change.

Key Points: 
  • The report highlights recommendations to further the scientific community's understanding of microbial processes of methane production and consumption to mitigate methane emissions and address climate change.
  • Microbes are major consumers and producers of methane, so understanding the diverse metabolic capabilities of microbes can help scientists better develop microbial solutions that address the issue of methane emissions.
  • The recommendations in the report aim to help advance the development of solutions that leverage microbes to mediate methane emissions from 4 main sources: enteric fermentation in ruminant animals (such as cows or sheep), animal wastes, rice paddies and landfills.
  • To complement the new report and serve as a practical next step, ASM will release a Microbial Methane Mitigation research roadmap in December, outlining current knowledge gaps and first-order research priorities for experts to use microbes to combat increasing methane emissions.

EmeritusDX appoints Dr. Vincent Funari, Renowned Genomics and Bioinformatics Expert, as Chief Scientific Officer

Retrieved on: 
Monday, October 30, 2023
CGP, Publication, PCR, Microorganism, Health, California Department of Health Care Services, Research, Cedars-Sinai Medical Center, Genomics, Cell, Medicine, NEJM, LDT, UCLA, NeoGenomics, Cancer, Clinical Genetics (journal), Patient, California Department, Medical device, Science, Grand

LAKE FOREST, Calif., Oct. 30, 2023 /PRNewswire-PRWeb/ -- EmeritusDX, a rapidly growing cancer diagnostic and information company, proudly announces the appointment of Dr. Vincent Funari, Ph.D. to its executive team. Effective October 30th, Dr. Funari will serve as the Chief Scientific Officer, bringing with him an extensive background in genomics and precision medicine.

Key Points: 
  • Effective October 30th, Dr. Funari will serve as the Chief Scientific Officer, bringing with him an extensive background in genomics and precision medicine.
  • "I am extremely excited to deploy cutting-edge technology to impact the patients with cancer that EmeritusDX serves."
  • Before this role, he contributed significantly as the Chief Scientific Officer at NeoGenomics, overseeing the successful launch of several comprehensive genomic panels(CGP).
  • Robert Embree, Chief Executive Officer of EmeritusDX, expressed the company's excitement: "EmeritusDX is thrilled to have such a well-respected genomics authority like Dr. Funari leading our research and innovation teams.

MediWound to Present Phase 2 EscharEx® Data at the Symposium on Advanced Wound Care (SAWC) Spring 2023

Retrieved on: 
Wednesday, April 26, 2023
DFU, Debridement, Education, VLU, SAWC, Microorganism, Therapy, Innovation, MS, DO, Cytokine, DPM, MD, Patient, Physician, Nursing, Wound healing, Wound, BBD, Pharmaceutical industry, Safety

YAVNE, Israel, April 26, 2023 (GLOBE NEWSWIRE) -- MediWound Ltd. (Nasdaq: MDWD), a fully-integrated biopharmaceutical company focused on next-generation enzymatic solutions for tissue repair, today announced the Company will present updated clinical data from the three EscharEx® Phase 2 trials at the 2023 Symposium on Advanced Wound Care (SAWC) Spring | Wound Healing Society taking place in National Harbor, Maryland on April 26-30, 2023.

Key Points: 
  • The session will be held in the Innovation Theater on April 29, 2023, at 7:30 am ET.
  • "We are thrilled to present our positive Phase 2 EscharEx data at this esteemed scientific conference.
  • “This event attracts top experts in the field of wound care from around the globe, and we look forward to presenting and sharing our data with them.
  • The 2023 SAWC Spring | WHS | DLS agenda features more than 80 high-impact sessions from expert presenters led by the giants and emerging voices in the field.